Zurcher Kantonalbank Zurich Cantonalbank acquired a new stake in Livent Corporation (NASDAQ:LTHM) during the first quarter, according to its most recent Form 13F filing with the SEC. The fund acquired 10,946 shares of the company’s stock, valued at approximately $134,000.

Several other large investors have also made changes to their positions in LTHM. FMR LLC bought a new stake in Livent during the 4th quarter worth approximately $30,461,000. BlackRock Inc. bought a new stake in Livent during the 4th quarter worth approximately $21,491,000. CIBC Private Wealth Group LLC bought a new stake in Livent during the 4th quarter worth approximately $18,402,000. Emerald Advisers LLC bought a new stake in Livent during the 4th quarter worth approximately $11,923,000. Finally, Emerald Mutual Fund Advisers Trust bought a new stake in Livent during the 4th quarter worth approximately $10,667,000.

Livent stock traded down $0.07 during trading on Wednesday, hitting $7.19. The stock had a trading volume of 6,526 shares, compared to its average volume of 2,994,819. Livent Corporation has a 1 year low of $7.06 and a 1 year high of $19.90.

Livent (NASDAQ:LTHM) last posted its quarterly earnings data on Tuesday, May 7th. The company reported $0.12 EPS for the quarter, missing the consensus estimate of $0.13 by ($0.01). The company had revenue of $98.30 million during the quarter, compared to analyst estimates of $105.43 million. The company’s quarterly revenue was down 4.4% on a year-over-year basis.

LTHM has been the subject of several recent analyst reports. Loop Capital set a $18.00 target price on Livent and gave the company a “buy” rating in a report on Friday, March 1st. Vertical Research lowered Livent from a “buy” rating to a “hold” rating in a report on Thursday, May 9th. Bank of America set a $16.00 target price on Livent and gave the company a “buy” rating in a report on Thursday, February 14th. Gabelli initiated coverage on Livent in a report on Wednesday, February 27th. They issued a “buy” rating and a $21.00 target price for the company. Finally, Zacks Investment Research lowered Livent from a “hold” rating to a “strong sell” rating in a report on Saturday, February 16th. One investment analyst has rated the stock with a sell rating, eight have assigned a hold rating and six have given a buy rating to the company. The stock presently has a consensus rating of “Hold” and an average price target of $16.47.

COPYRIGHT VIOLATION NOTICE: “Zurcher Kantonalbank Zurich Cantonalbank Takes $134,000 Position in Livent Corporation (LTHM)” was first posted by Watch List News and is owned by of Watch List News. If you are viewing this article on another website, it was copied illegally and reposted in violation of United States and international copyright laws. The correct version of this article can be accessed at https://www.watchlistnews.com/zurcher-kantonalbank-zurich-cantonalbank-takes-134000-position-in-livent-corporation-lthm/3018860.html.

About Livent

Livent Corporation manufactures and sells performance lithium compounds that are used primarily in energy storage, specialty polymers, and chemical synthesis application. The company offers lithium compounds for use in applications that have specific performance requirements, including battery-grade lithium hydroxide for use in high performance lithium-ion batteries; and supplies butyllithium, which is used as a synthesizer in the production of polymers and pharmaceutical products, as well as a range of specialty lithium compounds, including high purity lithium metal, which is used in the production of lightweight materials for aerospace applications and non-rechargeable batteries.

Further Reading: Special Dividends

Want to see what other hedge funds are holding LTHM? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Livent Corporation (NASDAQ:LTHM).

Institutional Ownership by Quarter for Livent (NASDAQ:LTHM)

Receive News & Ratings for Livent Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Livent and related companies with MarketBeat.com's FREE daily email newsletter.